PharmaEngine, Inc. (TPEX:4162)
Taiwan
· Delayed Price · Currency is TWD 81.10
-3.80 (-4.48%)
Jun 13, 2025, 1:30 PM CST
PharmaEngine Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 1,772 | 1,751 | 274.65 | 318.78 | 426.03 | 604.28 | Upgrade
|
| Depreciation & Amortization | 9.37 | 9.31 | 9.02 | 8.61 | 10.26 | 12.56 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | -5.53 | -45.46 | -0.83 | - | Upgrade
|
| Stock-Based Compensation | 1.01 | 1.3 | 3.38 | 2.37 | 0.09 | -1.06 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.01 | 0 | -0 | 0.01 | -0.22 | - | Upgrade
|
| Other Operating Activities | 372.67 | 344.77 | -33.31 | -54.79 | -81.69 | 69.67 | Upgrade
|
| Change in Accounts Receivable | 2.06 | -1,670 | -13.83 | 0.13 | 541.22 | -616.82 | Upgrade
|
| Change in Inventory | 18.57 | -12.48 | 18.47 | -28.94 | 19.31 | -0.62 | Upgrade
|
| Change in Accounts Payable | -30.4 | - | - | -2.05 | 8.62 | 12.06 | Upgrade
|
| Change in Other Net Operating Assets | 36.32 | 32.89 | 4.12 | 3.36 | 6.87 | -15.3 | Upgrade
|
| Operating Cash Flow | 2,181 | 456.73 | 256.97 | 202.01 | 929.67 | 64.77 | Upgrade
|
| Operating Cash Flow Growth | 768.67% | 77.74% | 27.21% | -78.27% | 1335.36% | 302.84% | Upgrade
|
| Capital Expenditures | -0.5 | -0.81 | -0.41 | -3.44 | -0.23 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -0.6 | - | -0.5 | - | -0.61 | Upgrade
|
| Investment in Securities | 113.15 | -114.67 | -854.48 | -183.98 | -105 | 1,765 | Upgrade
|
| Other Investing Activities | -0.14 | 0.55 | -0.59 | -0.2 | -1.77 | -0.07 | Upgrade
|
| Investing Cash Flow | 112.5 | -115.54 | -855.48 | -188.12 | -107 | 1,764 | Upgrade
|
| Long-Term Debt Repaid | - | -7.67 | -7.54 | -8 | -9.6 | -10.82 | Upgrade
|
| Net Debt Issued (Repaid) | -7.7 | -7.67 | -7.54 | -8 | -9.6 | -10.82 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -133.41 | -3.84 | Upgrade
|
| Common Dividends Paid | -215.44 | -215.44 | -287.19 | -387.71 | -363.99 | -72.83 | Upgrade
|
| Financing Cash Flow | -223.14 | -223.11 | -294.73 | -395.71 | -507 | -87.5 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | -0.75 | 1.56 | Upgrade
|
| Net Cash Flow | 2,071 | 118.08 | -893.24 | -381.81 | 314.93 | 1,743 | Upgrade
|
| Free Cash Flow | 2,181 | 455.92 | 256.56 | 198.57 | 929.44 | 64.77 | Upgrade
|
| Free Cash Flow Growth | 770.97% | 77.71% | 29.20% | -78.64% | 1335.01% | 308.12% | Upgrade
|
| Free Cash Flow Margin | 85.65% | 18.07% | 33.42% | 30.34% | 141.94% | 6.13% | Upgrade
|
| Free Cash Flow Per Share | 15.15 | 3.17 | 1.78 | 1.38 | 6.42 | 0.44 | Upgrade
|
| Cash Interest Paid | 0.15 | 0.18 | 0.31 | 0.08 | 0.21 | 0.44 | Upgrade
|
| Cash Income Tax Paid | 42.5 | 61.37 | 92.35 | 124.42 | 200.65 | 99.35 | Upgrade
|
| Levered Free Cash Flow | 1,702 | -19.65 | 159.87 | 105.29 | 723.9 | -50.51 | Upgrade
|
| Unlevered Free Cash Flow | 1,702 | -19.54 | 160.06 | 105.34 | 724.04 | -50.23 | Upgrade
|
| Change in Net Working Capital | -395.23 | 1,312 | 25.17 | 78.41 | -487.23 | 567.19 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.